Predicted Gene 15503 is identified through in silico analyses, utilizing computational methods to infer the presence of a gene within an organism's genome. These bioinformatic approaches detect gene signatures based on established genomic features such as open reading frames (ORFs), promoter regions, conserved splicing sites, and sequence homology to known genes. The label "Predicted Gene 15503" serves as a unique identifier, indicating its sequence among potentially thousands of predicted genes within a genomic database, reflecting its discovery or annotation sequence rather than its biological function or importance.The exact function, structure, and biological significance of Predicted Gene 15503 remain speculative until validated by empirical evidence. If it encodes a protein, this gene could be implicated in a myriad of cellular processes, from metabolic pathways and signal transduction to structural roles within the cell. Alternatively, it might produce non-coding RNAs involved in the regulation of gene expression, RNA splicing, or other critical cellular functions.
Experimental validation, including techniques like RNA sequencing (RNA-seq) to confirm transcription, proteomics to detect protein expression, and functional assays to understand the gene product's role, is essential for moving beyond prediction to confirmation and characterization of Predicted Gene 15503. These steps are crucial for elucidating its contributions to cellular physiology or disease processes.Research into such predicted genes is vital for expanding our comprehension of genomic and proteomic complexity. It opens new avenues for understanding how genomes encode biological functions and adapt to various environmental pressures. Through the experimental elucidation of Predicted Gene 15503 and others like it, scientists can uncover new insights into gene regulation, and evolutionary biology, illustrating the dynamic interplay between computational biology and experimental research in advancing our understanding of life at the molecular level.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin X intercalates into DNA and inhibits RNA synthesis, potentially impacting the transcription of the gene encoding predicted gene 15503. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis by interfering with translocation, potentially leading to reduced expression of the predicted gene 15503 protein at the translational level. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, potentially leading to reduced expression of the predicted gene 15503 protein and other proteins. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin inhibits protein phosphorylation and may impact the signaling pathways that regulate the expression of the predicted gene 15503 protein. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in protein synthesis, potentially impacting the translational regulation of the predicted gene 15503 protein. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation of proteins, potentially affecting the folding and trafficking of proteins including the predicted gene 15503 protein. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-Fluorouracil inhibits thymidylate synthase, an enzyme involved in DNA synthesis, potentially impacting the transcription of the gene encoding predicted gene 15503. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Anisomycin inhibits protein and DNA synthesis, potentially impacting the translational and transcriptional regulation of the predicted gene 15503 protein. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib inhibits the proteasome, the cellular complex responsible for degrading proteins, potentially impacting the degradation of the predicted gene 15503 protein. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
Erlotinib inhibits the activity of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase involved in cell signaling, potentially impacting the signaling pathways regulating the expression of the predicted gene 15503 protein. | ||||||